Anabolic-androgenic steroid use in the United States
- PMID: 8355384
Anabolic-androgenic steroid use in the United States
Abstract
Objective: To estimate the size of the anabolic-androgenic steroid (AAS) user population in the United States, to examine characteristics of AAS users, and to explore the association between AAS use and the use of other illicit drugs as well as self-reported aggressive behaviors.
Design: A cross-sectional study using data from the 1991 National Household Survey on Drug Abuse.
Study population: The survey covered the population aged 12 years and older living in households in the United States. The results of the survey were based on personal interviews combined with self-administered questionnaires from 32,594 respondents. These respondents were randomly selected by means of a stratified multistage area sample of the household population.
Results: Estimates based on data from the National Household Survey on Drug Abuse indicated that there are more than 1 million current or former AAS users in this country, with more than half of the lifetime user population being 26 years of age or older. More than 300,000 individuals used AAS in the past year. Males had higher levels of AAS use during their lifetime than females (0.9% and 0.1%, respectively; P < .01). The median age of first use of AAS for the study population was 18 years; for 12- to 17-year-olds, the median age of initiation was 15 years. Among 12- to 34-year-olds, AAS use was significantly and positively associated with the use of other illicit drugs (P < .05), cigarettes (12- to 17-year-olds only; P < .01), and alcohol (P < .01). Furthermore, AAS use is highly correlated with self-reported aggressive behavior (P < .01) and crimes against property (P < .01).
Conclusions: These results indicate that AAS use impacts a large number of men and women from various racial and age groups across the nation. While causal inferences cannot be made regarding the associations between AAS use and use of other drugs as well as antisocial behavior, these findings should enhance our ability to profile the typical AAS user.
Comment in
-
Use of anabolic-androgenic steroids: we are talking prevalence rates.JAMA. 1994 Feb 2;271(5):347. JAMA. 1994. PMID: 8283582 No abstract available.
-
Use of anabolic-androgenic steroids: we are talking prevalence rates.JAMA. 1994 Feb 2;271(5):347-8. JAMA. 1994. PMID: 8283583 No abstract available.
Similar articles
-
Psychological and physical impact of anabolic-androgenic steroid dependence.Pharmacotherapy. 2012 Oct;32(10):910-9. doi: 10.1002/j.1875-9114.2012.01123. Pharmacotherapy. 2012. PMID: 23033230
-
The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.Pharmacotherapy. 2011 Aug;31(8):757-66. doi: 10.1592/phco.31.8.757. Pharmacotherapy. 2011. PMID: 21923602
-
Trends in anabolic-androgenic steroid use among adolescents.Arch Pediatr Adolesc Med. 1997 Dec;151(12):1197-206. doi: 10.1001/archpedi.1997.02170490023005. Arch Pediatr Adolesc Med. 1997. PMID: 9412594
-
Adverse health effects of anabolic-androgenic steroids.Regul Toxicol Pharmacol. 2010 Jun;57(1):117-23. doi: 10.1016/j.yrtph.2010.02.001. Epub 2010 Feb 12. Regul Toxicol Pharmacol. 2010. PMID: 20153798 Review.
-
Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.Psychopharmacology (Berl). 2016 Feb;233(4):549-69. doi: 10.1007/s00213-015-4193-6. Epub 2016 Jan 12. Psychopharmacology (Berl). 2016. PMID: 26758282 Free PMC article. Review.
Cited by
-
Mediating mechanisms in a program to reduce intentions to use anabolic steroids and improve exercise self-efficacy and dietary behavior.Prev Sci. 2001 Mar;2(1):15-28. doi: 10.1023/a:1010082828000. Prev Sci. 2001. PMID: 11519372
-
In vivo MRI quantification of individual muscle and organ volumes for assessment of anabolic steroid growth effects.Steroids. 2008 Apr;73(4):430-40. doi: 10.1016/j.steroids.2007.12.011. Epub 2007 Dec 23. Steroids. 2008. PMID: 18241900 Free PMC article.
-
Behavioural manifestations of anabolic steroid use.CNS Drugs. 2005;19(7):571-95. doi: 10.2165/00023210-200519070-00002. CNS Drugs. 2005. PMID: 15984895 Review.
-
Lipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: the mutual crosstalk between ROS and NF-kB.J Cell Mol Med. 2016 Apr;20(4):601-12. doi: 10.1111/jcmm.12748. Epub 2016 Feb 1. J Cell Mol Med. 2016. PMID: 26828721 Free PMC article.
-
Illicit anabolic-androgenic steroid use.Horm Behav. 2010 Jun;58(1):111-21. doi: 10.1016/j.yhbeh.2009.09.006. Epub 2009 Sep 18. Horm Behav. 2010. PMID: 19769977 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous